FDA Investigator Demitria J Argiropoulos

Demitria J Argiropoulos has conducted inspections on 30 sites in 1 countries as of 13 Apr 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
30
Last Inspection Date:
13 Apr 2010
Investigator Role:
FDA Investigation Participant
Redica ID:
100001096
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Demitria J Argiropoulos:
Alice S Tsao, Althea A Williams, Amber D Brodas, Anissa M Vargas, Ann M Stewart, Anna M Alexander, Antonina Aydanian, Bijoy Panicker, Brandy N Lepage, Byungja E Marciante, Charanjeet Jassal, Charisse K Green, Charles Jewell, Dana A Razzano, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Felix Maldonado, Frank Verni, Freyja V Lynn, Gam S Zamil, Gifford Whitehurst, Jr, Gregson A Joseph, Helen B Ricalde, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, Jane C Chen, Jennifer L Bridgewater, Jogy George, Joseph J Vannelli, Joseph Milcetic, Juan Rjimenez Garcia, Juliana M Badalucco, Julie D Bringger, Karen L Kosar, Kerun Hardeo, Kevin A Gonzalez, Kristina L Conroy, Kwong P Lee, Lata C Mathew, PhD, Leena Thomas, Lori Peters, Manhar R Patel, Margaret E Sarles, Maria Joselopez Barragan, PhD, Marie Elena C Puleo, Marjorie A Shapiro, PhD, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spataro, Michael Levin, Michael R Dominick, Michael Serrano, Mihaly S Ligmond, Milan S Blake, Mindy M Chou, Nancy T Waites, Niketa Patel, Omotunde O Osunsanmi, Paige R Mccoy, Parul M Patel, Paul E Stein, Paul Mouris, Paula A Trost, Perry T Nichols, Philip F Istafanos, DMV, MS, Prabhu P Raju, Puspa Suresh Jayasekara, Rachael O Oyewole, Rajiv R Srivastava, Richard W Thornton, Robert C Steyert, Robert Jennings, Ruben C Quintana, Samina S Khan, Samuel T Walker, Sarah A Meehan, Sarah B Tanksley, Satheesh Thomas, Scott E Norris, Shari L Kahn, Simone E Pitts, Sony Mathews, Stella Yuen, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tej Poonai, Tina S Roecklein, Uduak M Inokon, Unnee Ranjan, Vivin George, Wayne E Seifert, Yvins Dezan, Zhongren Wu

Demitria J Argiropoulos's Documents

Publish Date Document Type Title
July, 2002 EIR ENDO USA, Inc. - EIR, 2002-07-01
May, 2010 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2010-06-15
March, 2008 FDA 483 Avon Products Inc - Form 483, 2008-03-03
February, 2010 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2010-02-09
August, 2003 EIR Elementis SRL, Inc. - EIR, 2003-08-01
February, 2009 FDA 483 Ultra Seal Corporation - Form 483, 2009-02-11
August, 2008 FDA 483 RIJ Pharmaceutical LLC - Form 483, 2008-08-04
November, 2008 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2008-11-03
May, 2008 FDA 483 Response Watson Laboratories, Inc. - Form 483R, 2008-06-10
July, 2005 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2005-07-25
July, 2004 FDA 483 Response Nepera, a Division of Rutherford Chemicals LLC - Form 483R, 2004-08-24
February, 2007 EIR ENDO USA, Inc. - EIR, 2007-02-28
October, 2006 FDA 483 Premier Brands of America Inc - Form 483, 2006-10-27
October, 2009 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2009-10-20
August, 2006 FDA 483 Perrigo New York, Inc. - Form 483, 2006-08-31
March, 2004 FDA 483 Response Ultra Seal Corporation - Form 483R, 2004-04-06
May, 2010 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2010-05-05
August, 2009 FDA 483 Pfizer Inc. - Form 483, 2009-08-10
August, 2008 FDA 483 Professional Disposables International, Inc. - Form 483, 2008-08-12
March, 2004 FDA 483 Ultra Seal Corporation - Form 483, 2004-03-08
November, 2009 EIR ENDO USA, Inc. - EIR, 2009-11-24
July, 2004 FDA 483 Nepera, a Division of Rutherford Chemicals LLC - Form 483, 2004-07-30
July, 2006 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2006-07-11
April, 2006 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2006-04-13
April, 2002 FDA 483 Lawrence Hospital - Form 483, 2002-04-25
November, 2008 FDA 483 Watson Laboratories, Inc. - Form 483, 2008-11-26
August, 2002 FDA 483 Silarx Pharmaceutical, Inc. - Form 483, 2002-08-08
June, 2006 FDA 483 International Pharmaceuticals & Biotechnology Laboratories - Form 483, 2006-06-01
May, 2009 FDA 483 Taro Pharmaceuticals U.S.A., Inc. - Form 483, 2009-05-29
September, 2002 FDA 483 Geritrex, LLC - Form 483, 2002-09-18
September, 2003 EIR Avon Products Inc - EIR, 2003-09-26
March, 2008 FDA 483 Premier Brands of America Inc - Form 483, 2008-03-17
January, 2004 EIR Breonics, Inc. - EIR, 2004-01-14
May, 2008 FDA 483 Watson Laboratories, Inc. - Form 483, 2008-05-13
July, 2004 EIR Nepera, a Division of Rutherford Chemicals LLC - EIR, 2004-07-30
April, 2002 EIR Lawrence Hospital - EIR, 2002-04-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more